2.5 mg semaglutide in syringe GLP-1 Pricing Preview Misread the syringe, started at

0:27A lot of times it'll just naturally pull in by itself, 0:30but just don't shoot it abruptly directly 0:32into the powder itself, 0:33but it dripped down the side of the vial

INDIANAPOLIS A clinical trial led by an Indiana University School of Medicine researcher found that weekly doses of semaglutide a medication typically prescribed to Type 2 diabetes patients improved blood sugar levels and weight loss for adult Type 1 diabetes patients who use automated insulin delivery systems and have a body mass index of 30 or higher

Three 20-week double-blind, placebo-controlled studies each with 34-week extensions were conducted to evaluate the efficacy and safety of sitagliptin in 410 pediatric patients aged 10 to 17 years with inadequately controlled type 2 diabetes, with or without insulin therapy (HbA1c 6.5-10% for patients not on insulin, HbA1c 7-10% for patients on insulin)

These findings provide direct genetic evidence that variation in the drug target genes contributes to inter-person variability in response and lay the foundation for precision medicine approaches in the treatment of obesity